The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Are mitochondria critical in the pathogenesis of Alzheimer's disease?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Intracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Bossy‐Wetzel, E., Newmeyer, D. D., & Green, D. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.37 · Cited by 1,225
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Self-citationSayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Holt, I. J., Harding, A. E., Petty, R., & MORGAN-HUGHES, J. A. (1990) · PubMed · Cited by 1,005
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890
Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885
Casari, G., De Fusco, M., Ciarmatori, S., Zeviani, M., Mora, M., Fernandez, P., De Michele, G., Filla, A., Cocozza, S., Marconi, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81203-9 · Cited by 830
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707
Mitochondrial α-Ketoglutarate Dehydrogenase Complex Generates Reactive Oxygen Species
Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E., Patel, M. S., & Beal, M. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1899-04.2004 · Cited by 688
Self-citationEvidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 663
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Self-citationSmall, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Ricci, J.-E., Muñoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A., Yadava, N., Scheffler, I. E., Ellisman, M. H., & Green, D. R. (2004) · Cell · doi:10.1016/j.cell.2004.05.008 · Cited by 602
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598
Anandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571
Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress
Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547
Brain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531
Electron transport chain defects in Alzheimer's disease brain
Parker, W. D., BA, J. P., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 494
Finch, C. E., & Tanzi, R. E. (1997) · Science · doi:10.1126/science.278.5337.407 · Cited by 492
β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities
Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., & Sharpe, M. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00681.x · Cited by 480
New Frontiers in Alzheimer's Disease Genetics
Tanzi, R. E., & Bertram, L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00476-7 · Cited by 463
Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients
Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Beal, M. F., Yang, C.-C., Gearing, M., Salvo, R., et al. (1993) · Genomics · doi:10.1006/geno.1993.1299 · Cited by 450
Self-citationManczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 430
Self-citationElevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease
Lovell, M. A., Ehmann, W. D., Mattson, M. P., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00108-5 · Cited by 412
Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
Mandelkow, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 401
Alzheimer's disease and Aβ toxicity: from top to bottom
Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086072 · Cited by 394
Pitkanen, S., & Robinson, B. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118798 · Cited by 388
Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
An introduction to the free radical hypothesis in Parkinson's disease
Olanow, C. W. (1992) · Annals of Neurology · doi:10.1002/ana.410320703 · Cited by 382
Hansen, J. J., Dürr, A., Cournu-Rebeix, I., Georgopoulos, C., Ang, D., Nielsen, M. N., Davoine, C.-S., Brice, A., Fontaine, B., Gregersen, N., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339935 · Cited by 374
Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
Reddy, P. H., Mani, G., Park, B. S., Jacques, J., Murdoch, G., Whetsell, W., Kaye, J., & Manczak, M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7203 · Cited by 372
Self-citationHigh aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
Lin, M. T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.133 · Cited by 366
Bioenergetic and oxidative stress in neurodegenerative diseases
Bowling, A. C., & Beal, M. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00055-b · Cited by 366
Self-citationYokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H., & Mizusawa, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.056 · Cited by 356
Bosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348
Abnormalities of mitochondrial enzymes in Alzheimer disease
Gibson, G. E., Sheu, K.-F. R., & Blass, J. P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050099 · Cited by 345
Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42
Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q.-X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-04.2005 · Cited by 327
Reddy, P. H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 326
Self-citationFerreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, A., Piemonte, F., Tozzi, G., Gaeta, L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420138 · Cited by 308
The Role of Oxidative Stress in Alzheimer Disease
Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 306
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Perry, G., Roder, H., Nunomura, A., Takeda, A., Friedlich, A. L., Zhu, X., Raina, A. K., Holbrook, N., Siedlak, S. L., Harris, P. L. R., et al. (1999) · NeuroReport · doi:10.1097/00001756-199908020-00035 · Cited by 283
Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275
Cybrids in Alzheimer's disease: a cellular model of the disease?
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272
Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy.
Brown, M. D., Voljavec, A. S., Lott, M. T., Torroni, A., Yang, C. C., & Wallace, D. C. (1992) · Genetics · doi:10.1093/genetics/130.1.163 · Cited by 272
Kruman, I. I., Pedersen, W. A., Springer, J. E., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7190 · Cited by 268
Yates, C. M., Butterworth, J., Tennant, M. C., & Gordon, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04948.x · Cited by 263
The Protein Import System of Mitochondria
Schatz, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31763 · Cited by 261
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
Cardoso, S. M., Santana, I., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 261
Cybrids in Alzheimer's disease: A cellular model of the disease?
Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260
Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
Mattson, M. P., Partin, J., & Begley, J. G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00763-x · Cited by 259
Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249
Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease
Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 239
Perry, E. K., Perry, R. H., Tomlinson, B. E., Blessed, G., & Gibson, P. H. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90220-7 · Cited by 236
MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons
Mandelkow, E.-M., Thies, E., Trinczek, B., Biernat, J., & Mandelkow, E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401085 · Cited by 236
Experimental therapeutics in transgenic mouse models of Huntington's disease
Beal, M. F., & Ferrante, R. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1386 · Cited by 222
Self-citationIPF 2α -I: An index of lipid peroxidation in humans
Praticò, D., Barry, O. P., Lawson, J. A., Adiyaman, M., Hwang, S.-W., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219
Keller, J. N., Guo, Q., Holtsberg, F. W., Bruce-Keller, A. J., & Mattson, M. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04439.1998 · Cited by 215
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
Behl, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050955 · Cited by 211
Takeda, A., Smith, M. A., Avilá, J., Nunomura, A., Siedlak, S. L., Zhu, X., Perry, G., & Sayre, L. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751234.x · Cited by 203
Manczak, M., Jung, Y., Park, B. S., Partovi, D., & Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02884.x · Cited by 193
Self-citationTrounce, I., Neill, S., & Wallace, D. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8334 · Cited by 192
A mitochondrial DNA clone is associated with increased risk for Alzheimer disease.
Hutchin, T., & Cortopassi, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6892 · Cited by 186
Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease
Mastrogiacomo, F., Bergeron, C., & Kish, S. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07436.x · Cited by 176
Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.
Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Pa, T., Krebs, C. T., Bennett, J. C., Parks, J. K., Swerdlow, R. H., et al. (2000) · PubMed · Cited by 176
Marques, C. A., Keil, U., Bonert, A., Steiner, B., Haass, C., Müller, W. E., & Eckert, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212265200 · Cited by 175
Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease
Butterworth, R. F., & Besnard, A. M. (1990) · Metabolic Brain Disease · doi:10.1007/bf00997071 · Cited by 164
Metabolic, Metallic, and Mitotic Sources of Oxidative Stress in Alzheimer Disease
Smith, M. A., Nunomura, A., Zhu, X., Takeda, A., & Perry, G. L. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192198 · Cited by 164
Blass, J. P. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10087 · Cited by 161
The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
Blass, J. P., & Gibson, G. E. (1991) · PubMed · Cited by 160
Mitochondrial Inheritance in a Mitochondrially Mediated Disease
Egger, J., & Wilson, J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090304 · Cited by 158
Metabolic Dysfunction in Familial, but Not Sporadic, Amyotrophic Lateral Sclerosis
Browne, S. E., Bowling, A. C., Baik, M. J., Gurney, M. E., Brown, R. H., & Beal, M. F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010281.x · Cited by 149
Self-citationLin, F. H., Lin, R. J., Wisniewski, H. M., Hwang, Y., Grundke, I., Healy-Louie, G., & Iqbal, K. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80136-6 · Cited by 148
Localization of the Wilson’s disease protein product to mitochondria
Lutsenko, S., & Cooper, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6004 · Cited by 145
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Liu, Q., Smith, M. A., Ávila, J., DeBernardis, J. F., Kansal, M. M., Takeda, A., Zhu, X., Nunomura, A., Honda, K., Moreira, P. I., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.005 · Cited by 145
Askanas, V., McFerrin, J., Baqué, S., Alvarez, R. B., Sarkozi, E., & Engel, W. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1314 · Cited by 144
Amyloid ?? peptide induces cytochrome c release from isolated mitochondria
Kim, H.-S., Lee, J.-H., Lee, J.-P., Kim, E.-M., Chang, K.-A., Park, C. H., Jeong, S.-J., Wittendorp, M. C., Seo, J.-H., Choi, S.-H., et al. (2002) · NeuroReport · doi:10.1097/00001756-200210280-00032 · Cited by 124
Lyras, L., Perry, R. H., Perry, E. K., Ince, P. G., Jenner, A. M., Jenner, P. G., & Halliwell, B. B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010302.x · Cited by 121
Evidence for Physiological Down-regulation of Brain Oxidative Phosphorylation in Alzheimer's Disease
Chandrasekaran, K., Hatanpaa, K. J., Brady, D. R., & Rapoport, S. I. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0180 · Cited by 117
Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease
Kirby, D. M., Boneh, A., Chow, C. W., Ohtake, A., Ryan, M. T., Thyagarajan, D. E., & Thorburn, D. R. (2003) · Annals of Neurology · doi:10.1002/ana.10687 · Cited by 117
Mattson, M. P., Gary, D. S., Chan, S. L., & Duan, W. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670151 · Cited by 113
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
Jiménez‐Jiménez, F. J., de Bustos, F., Molina, J. A., Benito‐León, J., Tallón-Barranco, A., Gasalla, T., Pareja, M. O., Guillamón, F., Rubio‐Terres, C., Arenas, J., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291887 · Cited by 112
Simonian, N. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00010 · Cited by 111
Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients
Brown, M. D., Shoffner, J. M., Kim, Y. L., Jun, A. S., Graham, B. H., Cabell, M. F., Gurley, D. S., & Wallace, D. C. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960122)61:3<283::aid-ajmg15>3.0.co;2-p · Cited by 107
Oxidative phosphorylation defects and Alzheimer's disease
Shoffner, J. M. (1997) · Neurogenetics · doi:10.1007/s100480050002 · Cited by 106
Mutant and Wild-Type α-Synuclein Interact with Mitochondrial Cytochrome C Oxidase
Elkon, H., Don, J., Melamed, E., Ziv, I., Shirvan, A., & Offen, D. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:3:229 · Cited by 106
Chandrasekaran, K., Hatanpaa, K. J., Rapoport, S. I., & Brady, D. R. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00191-x · Cited by 105
Luo, X., Pitkänen, S., Kassovska‐Bratinova, S., Robinson, B. H., & Lehotay, D. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119481 · Cited by 105
Genotype and phenotype in Alzheimer's disease
Holmes, C. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.131 · Cited by 104
Su, J. H., Anderson, A. J., Cribbs, D. H., Tu, C. H., Tong, L., Kesslak, P. J., & Cotman, C. W. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00019-0 · Cited by 101
Aliev, G., Seyidova, D., Lamb, B. T., Obrenovich, M. E., Siedlak, S. L., Vinters, H. V., Friedland, R. P., LaManna, J. C., Smith, M. A., & Perry, G. L. (2003) · Neurological Research · doi:10.1179/016164103101201977 · Cited by 96
Hofmann, S., Rothbauer, U., Mühlenbein, N., Neupert, W., Gerbitz, K.-D., Brunner, M., & Bauer, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201154200 · Cited by 93
Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.011 · Cited by 92
Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases
Egensperger, R., Kösel, S., Schnopp, N. M., Mehraein, P., & Graeber, M. B. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01301.x · Cited by 90
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88
Coster, R. V., Seneca, S., Smet, J., Hecke, R. V., Gerlo, E., Devreese, B. V., BEEUMEN, J. V., Leroy, J. G., Meırleır, L. D., & Lissens, W. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10202 · Cited by 88
Smith, M., Drew, K. L., Nunomura, A., Takeda, A., Hirai, K., Zhu, X., Atwood, C. S., Raina, A. K., Rottkamp, C. A., Sayre, L. M., et al. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00123-1 · Cited by 83
Brockmann, K., Bjornstad, A., Dechent, P., Korenke, C. G., Smeitink, J., Trijbels, J. M. F., Athanassopoulos, S., Villagran, R., Skjeldal, O. H., Wilichowski, E., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10232 · Cited by 81
The other, forgotten genome: mitochondrial DNA and mental disorders
Kato, T. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000926 · Cited by 81
Co-association of parkin and α-synuclein
Choi, P., Golts, N., Snyder, H. M., Chong, M., Petrucelli, L., Hardy, J., Sparkman, D. R., Cochran, E. J., Lee, J. M., & Wolozin, B. L. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00017 · Cited by 78
Pitkänen, S., Merante, F., McLeod, D. R., Applegarth, D. A., Tong, T., & Robinson, B. H. (1996) · Pediatric Research · doi:10.1203/00006450-199603000-00021 · Cited by 66
Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815203 · Cited by 65
Huang, H.-M., Zhang, H., Xu, H., & Gibson, G. E. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00222-3 · Cited by 61
Mitochondrial myopathies and encephalomyopathies
Schapira, A. H. V., & Cock, H. R. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00540.x · Cited by 61
NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex
Carlson, M. D., Penney, J. B., & Young, A. B. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90120-z · Cited by 60
New insights into Parkinson?s disease
Chung, K. K. K., Dawson, V. L., & Dawson, T. M. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1304-9 · Cited by 59
New patterns of inheritance in mitochondrial disease
Schwartz, M., & Vissing, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.037 · Cited by 57
Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome
Pecina, P., Čapková, M., Chowdhury, S. R., Drahota, Z., Dubot, A., Pecinová, A., Hansíková, H., Houšt'ková, H., Zeman, J., Godinot, C., et al. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00127-3 · Cited by 54
Thome, J., Gsell, W., Rösier, M., Kornhuber, J., Frölich, L., Hashimoto, E., Zielke, B., Wiesbeck, G. A., & Riedcrer, P. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00583-8 · Cited by 53
Alzheimer's disease: Cause(s), diagnosis, treatment and care
(1997) · Geriatric Nursing · doi:10.1016/s0197-4572(97)90367-0 · Cited by 52
Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1α deficiency
Marsac, C., Benelli, C., Desguerre, I., et al. (1997) · Human Genetics · doi:10.1007/s004390050449 · Cited by 51
Models of Alzheimer’s disease: cellular and molecular aspects
Hoyer, S. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_2 · Cited by 48
Oxidative Mechanisms in β-Amyloid Cytotoxicity
Davis, J. B. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0060 · Cited by 47
Metabolic alterations common to neural and non‐neural cells in alzheimer's disease
Blass, J. P. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030708 · Cited by 45
Differential alterations in antioxidant capacity in cells from Alzheimer patients
Gibson, G. E., Zhang, H., Sheu, K.-F. R., & Park, L. C. H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00057-0 · Cited by 44
Famulari, A. L., Marschoff, E. R., Llesuy, S., Kohan, S., Serra, J. A., Domínguez, R. O., Repetto, M. G., Reides, C. G., & de Lustig, E. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00163-3 · Cited by 40
Meırleır, L. D., Lissens, W., Benelli, C., Ponsot, G., Desguerre, I., Marsac, C., Rodriguez, D., Saudubray, J., Poggi, F., & Liebaers, I. (1994) · Pediatric Research · doi:10.1203/00006450-199412000-00004 · Cited by 39
Tulinius, M., Moslemi, A. ‐., Darín, N., Westerberg, B., Wiklund, L., Holme, E., & Oldfors, A. (2003) · Neuropediatrics · doi:10.1055/s-2003-39607 · Cited by 38
Nakano, K., Takase, C., Sakamoto, T., Nakagawa, S., Inazawa, J., Ohta, S., & Matuda, S. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb20010.x · Cited by 35
Strazielle, C., Sturchler, C., Staufenbiel, M., & Lalonde, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00037-x · Cited by 35
Tysoe, C. J., Robinson, D., Brayne, C., Dening, T., Paykel, E. S., Huppert, F. A., & Rubinsztein, D. C. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.12.1002 · Cited by 26
Ali, G., Wasco, W., Cai, X., Szabo, P., Sheu, K. R., Cooper, A. J. L., Gaston, S. M., Gusella, J. F., Tanzi, R. E., & Blass, J. P. (1994) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02290679 · Cited by 20
The Cellular Energy Crisis: Mitochondria and Cell Death
Waterhouse, N. J. (2003) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200301000-00017 · Cited by 13
Cerebral Metabolic Impairments
Blass, J. P. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch15 · Cited by 13
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Research works printed but not linked: 8
- Cavelier, 2001, MtDNA mutations in maternally inherited diabetes: presence of the 3397 ND1 mutation previously associated with Alzheimer's and Parkinson's disease, Hereditas, 135, 65, 10.1111/j.1601-5223.2001.00065.x · doi:10.1111/j.1601-5223.2001.00065.x
- Chandrasekaran, 1994, Impairment in gene expression ox oxidative metabolism in vulnerable brain regions in Alzheimer's disease, Neurobiol. Aging, 14, 343
- Petruzzella, 2003, Atypical Leigh syndrome associated with the D393N mutation in the mitochondrial ND5 subunit, Neurology, 61, 1017, 10.1212/01.WNL.0000080363.10902.E9 · DOI
- Roesch, 2004, The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a–TIMM13 complex, Hum. Mol. Genet., 13, 2101, 10.1093/hmg/ddh217 · DOI
- Sheu, 1996, A gene locus of dihyrolipoyl sucinyltransferase (DLST) is associated with Alzheimer's disease, J. Neurochem., 66, S10
- Sheu, 1997, α-Ketoacid dehydrogenase complexes in inborn errors of metabolism and neurodegeneration, J. Neurochem., 69, S2
- Sheu, 1998, Immunochemical characterization of the deficiency of the alpha-ketoglutarate dehydrogenase complex in thiamine-deficient rat brain, J. Neurochem., 70, 1143, 10.1046/j.1471-4159.1998.70031143.x · doi:10.1046/j.1471-4159.1998.70031143.x
- Williams, 2001, A novel mutation in SURF1 causes skipping of exon 8 in a patient with cytochrome c oxidase-deficient leigh syndrome and hypertrichosis, Mol. Genet. Metab., 73, 340, 10.1006/mgme.2001.3206 · doi:10.1006/mgme.2001.3206
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,298
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Self-citationMitochondrial fragmentation in neurodegeneration.
Knott, A. B., Perkins, G., Schwarzenbacher, R., & Bossy-Wetzel, E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2417 · Cited by 1,002
Metadata
- Authors
- Reddy, P. H., & Beal, M. F.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 49
- Issue
- 3
- Pages
- 618-632
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2017115444
- Cited by
- 289
- References
- 154
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.